Dna Group (T.R.) Ltd (DNA.TA)
Dna Group (T.R.) Ltd operates in the Biotechnology industry of the Healthcare sector, headquartered in Tel Aviv, IL. The stock last traded at $110.90, up 0.00% on the session, giving a market capitalisation of $136.6M. Its beta of -0.01 implies it has historically moved less than the broad market.
Dna Group (T.R.) Ltd, along with its subsidiaries, specializes in the innovation, production, and worldwide distribution of proprietary ultrasound technologies. These advanced systems are utilized to evaluate bone strength and density, as well as to detect and monitor calcium leakage associated with osteoporosis in both adult and pediatric patients. The company's offerings are employed by trained physicians, nurses, and operators within hospitals, clinics, pharmacies, and various other healthcare environments across Israel, North America, East Asia, and international markets. Beyond its core ultrasound business, the group is also involved in the creation of oral medications. Established in 2004 and based in Tel Aviv-Yafo, Israel, the company was formerly known as D.N.A Biomedical Solutions Ltd. before adopting its current name in November 2022.
Dna Group (T.R.) Ltd is most often compared with the following Healthcare names: